USFDA grants ‘tentative approval’ to Zydus’ mental health drug
The USFDA has granted Zydus Lifesciences Limited ‘tentative approval’ to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.
Drugs
Pharma
Health
Pharma
Uncategorized
Domestic formulations to aid pharma growth: ICICI Direct
The Indian pharmaceutical industry is expected to witness “decent growth” during the three-month period through 31 March 2023, mainly led by continued traction.
Drugs
Pharma
Eiasi files market authorization for Alzheimer’s drug in Japan
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Drugs
Health
Pharma
Decade-long study pinpoints baffling causes of epilepsy in children
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure.
Drugs
Medical
Pharma
UK’s AI stroke machine to cut treatment time by 60 mts
An artificial intelligence-powered machine can reduce the treatment time for stroke patients by 60 minutes and free up clinicians’ time.
Drugs
Pharma
WHO issues medical product alert on Marion’s syrups
The WHO has issued a Medical Product Alert on India’s Marion Biotech’s Ambronol and DOK-1 Max syrups as they failed to meet quality.
Drugs
Pharma
California sues insulin makers, PBMs, for skyrocketing prices
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Drugs
Pharma
Insilico announces positive phase 1 trial results for AI-designed IPF drug
Insilico Medicine, an AI biotech company, announced positive results from the Phase 1 clinical trial of INS018_055, its first-in-class drug for idiopathic pulmonary fibrosis.
Medical
Pharma
BioNTech signs MoU with UK govt to start clinical trials for mRNA cancer vaccine
BioNTech signs MoU with the British government to start mRNA cancer trials